Nanogen asked to provide more data of homegrown Nano Covax
Nanogen Pharmaceutical Biotechnology JSC has been asked to provide more data for consideration before a registration certificate of conditional circulation for its Nano Covax can be granted.
Nano Covax, a recombinant spike protein vaccine, is the forerunner in the race for domestically produced COVID-19 vaccine. (Photo: VNA)
Hanoi (VNA) - Nanogen Pharmaceutical Biotechnology JSC has been asked toprovide more data for consideration before a registration certificate of conditionalcirculation for its Nano Covax can be granted.
Therequest was made by the Advisory Council for the Registration of Circulation ofDrugs and Medicinal Ingredients after a meeting held on August 29.
Ina press release, the council said it and relevant units had carefully consideredthe application, adding that the dossier had been appraised by the LegalSubcommittee twice; by the Quality Subcommittee four times,and by the Pharmacology and Clinical Subcommittee three times.
The AdvisoryCouncil acknowledged the results obtained for the application for a registrationcertificate of circulation of the Nano Covax vaccine which had been appraisedby the expert subcommittees, and accepted by the Ethics Council. Atthe same time, the Advisory Council requested the company continue tosupplement and clarify some content regarding application qualityand pharmacological and clinical records.
Regardingpharmacological and clinical records, the council asked for moreinformation regarding safety, immunogenicity and protection effect.
Specifically,the company needs to add and update data on safety for allsubjects who have been vaccinated with at least one dose of the vaccine up tothe present time and clearly explain the cases of serious adverse events (SAE).
The councilalso asked for more data according to the latest amendment protocolapproved by the Ethics Committee, including: assessment of immunogenicity onnew strains (for example Delta strain, UK strain, and others) and sample sizefor immunogenicity assessment should be carried out in accordance with theapproved research protocol.
Regardingthe protection effect, it isrequired that the enterprise coordinate with the research teamto analyse and discuss the relationship between the immunogenicity of thevaccine and the protection effectiveness of at least 50 percent (accordingto the guidance of the World Health Organization).
NanoCovax, a recombinant spike protein vaccine, is the forerunner in the race fordomestically produced COVID-19 vaccine, followed by COVIVAC from the Instituteof Vaccines and Biologic Medical and mRNA vaccine ARCT-154 (byArcturus and VinBioCare) just starting phase 2 trials./.
The vaccine market in Vietnam - a tropical country with a hot and humid climate - is forecast to be large and has a high growth rate in the coming years, health experts said.
The National Committee for Ethics in Biomedical Research under the Ministry of Health (MoH) has agreed that the mid-term results from Nano Covax's phase 3 clinical trials will be submitted to the Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients for considering the issuance of a registration certificate for the conditional circulation of the vaccine.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Nano Covax, a recombinant spike protein vaccine, is the forerunner in the race for domestically produced COVID-19 vaccine. (Photo: VNA) 
